# DROSPIRENONE AND ETHINYL ESTRADIOL
> **ANDA205876** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2016-09-21
## Drug
- **FDA Application Number:** ANDA205876
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROSPIRENONE AND ETHINYL ESTRADIOL
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2016-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205876)
---
*AI Analytics · CC0 1.0*